deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT02887521

Pulmonary Rehabilitation Before Lung Cancer Resection

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Chronic Obstructive Pulmonary Disease (COPD) Non-small Cell Lung Cancer (NSCLC)
Interventions education pedometer rehabilitation surgery
Updated 18 times since 2017 Last updated: Jan 15, 2025 Started: Feb 28, 2018 Primary completion: Apr 22, 2019 Completion: Sep 25, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor accrual

Other terminated trials from Alliance for Clinical Trials in Oncology

See all terminations from Alliance for Clinical Trials in Oncology

Other Chronic Obstructive Pulmonary Disease (COPD) trials with similar outcome

Browse all Chronic Obstructive Pulmonary Disease (COPD) trials

This PHASE3 trial investigates Chronic Obstructive Pulmonary Disease (COPD) and Non-small Cell Lung Cancer (NSCLC) and is currently terminated or withdrawn. Alliance for Clinical Trials in Oncology leads this study, which shows 18 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~May 2018 · 7 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Jun 2019 · 5 months · monthly snapshot~Jun 2019 – ~Nov 2019 · 5 months · monthly snapshot~Nov 2019 – ~Jul 2020 · 8 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – present · 16 months · monthly snapshot

Change History

18 versions recorded

  1. Mar 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Mar 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jul 2020 — Jan 2021 [monthly]

    Terminated PHASE3

▶ Show 13 earlier versions

  1. Nov 2019 — Jul 2020 [monthly]

    Terminated PHASE3

    Status: Active Not Recruiting → Terminated

  2. Jun 2019 — Nov 2019 [monthly]

    Active Not Recruiting PHASE3

  3. Jan 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE3

  4. Dec 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Sep 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  6. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  7. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  8. Oct 2017 — May 2018 [monthly]

    Recruiting PHASE3

  9. Jul 2017 — Oct 2017 [monthly]

    Recruiting PHASE3

  10. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE3

  11. Apr 2017 — Jun 2017 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  12. Feb 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE3

  13. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)
Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations